BLOG: ORCID Adoption in the Pharma Community BuysMatthew FarrowPaul SabirSarah 2019 ORCID have been collaborating with the Open Pharma team on various outreach activities over the last two years. In this post, jointly authored by our former Engagement Director, Matt Buys, and Paul Farrow, Group Communications Director and Sarah Sabir, Associate Medical Writer, both at Oxford PharmaGenesis, we look at the adoption of ORCID across various organisations in the pharmaceutical research community.